AC Immune SA

Research AC Immune SA (ACIU) on Bullrun: market cap USD 270.72M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerACIU
• ExchangeNASDAQ
• CountrySwitzerland
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 270.72M
• Financial periodQ1 2026
• RevenueUSD 1.12M
• Net income-USD 14.80M

Valuation Snapshot

latest market cap is USD 270.72M.

About AC Immune SA

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company's SupraAntigen and Morphomer platforms are designed to generate biologics and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases.

Frequently asked questions

What is AC Immune SA's market cap?

AC Immune SA's market capitalization is USD 270.72M.

What does AC Immune SA do?

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.